Deerfield Management as of June 30, 2017
Portfolio Holdings for Deerfield Management
Deerfield Management holds 83 positions in its portfolio as reported in the June 2017 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Avexis | 10.1 | $190M | 2.3M | 82.16 | |
Gilead Sciences (GILD) | 6.4 | $120M | 1.7M | 70.78 | |
Horizon Pharma | 5.7 | $107M | 9.0M | 11.87 | |
NxStage Medical | 5.1 | $96M | 3.8M | 25.07 | |
Horizon Pharma Plc convertible security | 3.4 | $64M | 74M | 0.86 | |
Mylan Nv | 2.8 | $53M | 1.4M | 38.82 | |
Mallinckrodt Pub | 2.8 | $53M | 1.2M | 44.81 | |
McKesson Corporation (MCK) | 2.8 | $52M | 315k | 164.54 | |
Aerie Pharmaceuticals | 2.7 | $51M | 961k | 52.55 | |
Isis Pharmaceuticals Inc Del note 1.000%11/1 | 2.4 | $45M | 42M | 1.06 | |
Kempharm Inc note 5.500% 2/0 | 2.4 | $44M | 75M | 0.59 | |
Flamel Technologies Sa | 2.1 | $40M | 3.7M | 11.03 | |
Trn 4% 04/01/45 | 2.0 | $38M | 48M | 0.80 | |
Glaukos (GKOS) | 2.0 | $37M | 895k | 41.47 | |
Gw Pharmaceuticals Plc ads | 1.9 | $36M | 360k | 100.25 | |
Endologix, Inc. 3.25% 11/01/2020 | 1.8 | $34M | 41M | 0.85 | |
Intersect Ent | 1.8 | $33M | 1.2M | 27.95 | |
Audentes Therapeutics | 1.8 | $33M | 1.7M | 19.13 | |
Lannett Company | 1.7 | $31M | 1.5M | 20.40 | |
Nevro Corp note 1.750% 6/0 | 1.6 | $30M | 28M | 1.07 | |
Editas Medicine (EDIT) | 1.5 | $29M | 1.7M | 16.78 | |
Nevro (NVRO) | 1.5 | $28M | 376k | 74.43 | |
Dbv Technologies S A | 1.3 | $24M | 665k | 35.71 | |
Portola Pharmaceuticals | 1.3 | $24M | 419k | 56.17 | |
BioCryst Pharmaceuticals (BCRX) | 1.2 | $22M | 4.0M | 5.56 | |
Intercept Pharmas conv | 1.2 | $22M | 23M | 0.98 | |
Selecta Biosciences | 1.1 | $21M | 1.1M | 19.86 | |
Syros Pharmaceuticals | 1.1 | $20M | 1.3M | 16.09 | |
Loxo Oncology | 1.1 | $20M | 251k | 80.19 | |
Aetna | 1.1 | $20M | 130k | 151.83 | |
Patterson Companies (PDCO) | 1.0 | $19M | 393k | 46.95 | |
Dex (DXCM) | 1.0 | $18M | 248k | 73.15 | |
Fluidigm Corporation convertible cor | 0.9 | $17M | 28M | 0.62 | |
Oxford Immunotec Global | 0.8 | $16M | 946k | 16.82 | |
Advanced Accelerat spon ads each rep 2 ord | 0.8 | $15M | 393k | 39.04 | |
Galapagos Nv- (GLPG) | 0.8 | $14M | 188k | 76.52 | |
Anthem (ELV) | 0.8 | $14M | 75k | 188.13 | |
Wave Life Sciences (WVE) | 0.7 | $14M | 747k | 18.60 | |
Aac Holdings | 0.7 | $14M | 2.0M | 6.93 | |
Aegerion Pharmaceuticals 2% Du cvbond | 0.7 | $13M | 17M | 0.81 | |
Recro Pharma | 0.7 | $13M | 1.9M | 7.03 | |
Anaptysbio Inc Common (ANAB) | 0.7 | $13M | 553k | 23.93 | |
eHealth (EHTH) | 0.7 | $13M | 690k | 18.80 | |
Xencor (XNCR) | 0.6 | $12M | 562k | 21.11 | |
Cytomx Therapeutics (CTMX) | 0.6 | $12M | 757k | 15.50 | |
Ardelyx (ARDX) | 0.6 | $12M | 2.3M | 5.10 | |
Ascendis Pharma A S (ASND) | 0.6 | $12M | 420k | 27.76 | |
Axogen (AXGN) | 0.6 | $11M | 674k | 16.75 | |
Argenx Se (ARGX) | 0.6 | $11M | 509k | 21.21 | |
Neos Therapeutics | 0.6 | $11M | 1.5M | 7.30 | |
Molina Healthcare (MOH) | 0.6 | $11M | 152k | 69.18 | |
Blueprint Medicines (BPMC) | 0.6 | $10M | 203k | 50.67 | |
Aclaris Therapeutics (ACRS) | 0.5 | $10M | 375k | 27.12 | |
Epizyme | 0.5 | $10M | 662k | 15.10 | |
Allscripts Healthcare So conv | 0.5 | $9.9M | 9.7M | 1.02 | |
Sangamo Biosciences (SGMO) | 0.5 | $9.6M | 1.1M | 8.80 | |
Centene Corporation (CNC) | 0.5 | $9.5M | 119k | 79.88 | |
Puma Biotechnology (PBYI) | 0.5 | $9.1M | 104k | 87.40 | |
Steadymed | 0.5 | $9.1M | 1.4M | 6.30 | |
Nivalis Therapeutics | 0.5 | $9.0M | 3.7M | 2.41 | |
Invuity | 0.5 | $8.5M | 1.2M | 7.25 | |
Select Medical Holdings Corporation (SEM) | 0.4 | $7.7M | 505k | 15.35 | |
Arena Pharmaceuticals | 0.4 | $7.0M | 417k | 16.87 | |
Alimera Sciences | 0.3 | $6.6M | 4.8M | 1.39 | |
Axovant Sciences | 0.3 | $5.5M | 239k | 23.19 | |
Biohaven Pharmaceutical Holding | 0.3 | $5.4M | 217k | 25.00 | |
Myovant Sciences | 0.2 | $4.7M | 401k | 11.70 | |
Sierra Oncology | 0.2 | $4.1M | 3.5M | 1.17 | |
Foamix Pharmaceuticals | 0.2 | $3.8M | 817k | 4.64 | |
Akari Therapeutics | 0.2 | $3.8M | 818k | 4.61 | |
Myokardia | 0.2 | $3.7M | 280k | 13.10 | |
Mannkind (MNKD) | 0.2 | $3.8M | 2.7M | 1.41 | |
BioScrip | 0.2 | $3.6M | 1.3M | 2.71 | |
Agile Therapeutics | 0.2 | $3.6M | 955k | 3.75 | |
Jounce Therapeutics | 0.2 | $3.5M | 248k | 14.03 | |
Kempharm | 0.1 | $2.8M | 705k | 4.00 | |
Aralez Pharmaceuticals | 0.1 | $2.2M | 1.6M | 1.35 | |
Proteon Therapeutics | 0.1 | $1.9M | 1.2M | 1.53 | |
Obalon Therapeutics | 0.1 | $1.8M | 183k | 9.91 | |
Ra Pharmaceuticals | 0.1 | $1.5M | 83k | 18.74 | |
Voyager Therapeutics (VYGR) | 0.1 | $1.1M | 118k | 8.96 | |
Essa Pharma | 0.0 | $779k | 1.4M | 0.55 | |
Proteostasis Therapeutics In | 0.0 | $81k | 17k | 4.70 |